Infographics on risks associated with COVID-19 and the willingness to get the AstraZeneca vaccine: two randomized online experiments
Abstract Background Germans hesitated to get vaccinated with AstraZeneca in the COVID-19 pandemic after reports of blood clots. Methods In two preregistered online experiments with stratified randomization (Study 1 N = 824, Study 2: N = 1,056), we tested whether providing evidence-based benefit-risk...
Main Authors: | Lisa Felgendreff, Regina Siegers, Leonie Otten, Cornelia Betsch |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12889-024-18057-0 |
Similar Items
-
Thromboembolism and the Oxford-AstraZeneca vaccine
by: Perera, R, et al.
Published: (2021) -
Malaysia to use AstraZeneca vaccine
by: Povera, Adib
Published: (2021) -
Busting the Breast Cancer with AstraZeneca’s Gefitinib
by: S. Chemmalar, et al.
Published: (2023-01-01) -
Lipschütz ulcers after AstraZeneca COVID-19 vaccination
by: Maria Bracho-Borro, et al.
Published: (2023-08-01) -
The first report of myocarditis followed by AstraZeneca vaccination in Iran
by: Karo Servatyari, et al.
Published: (2022-06-01)